![]() |
|
|
Vol. 30, Issue 2, 220-223, February 2002
-Estradiol-D-17
-Glucuronide
on the Rat Organic Anion Transporting Polypeptide 2-Mediated Transport
Differs Depending on Substrates
Graduate School of Pharmaceutical Sciences, the University of
Tokyo, Bunkyo-ku, Tokyo, Japan (D.S., H.K., Y.Su.); School of
Pharmaceutical Sciences, Kitasato University, Minato-ku, Tokyo, Japan
(Y.Sh.); Department of Neurophysiology, 1st Department of Surgery,
Tohoku University School of Medicine, Sendai, Japan (T.A.)
Rat organic anion transporting polypeptide 2 (rOatp2) is a member
of the OATP family. It exhibits broad substrate specificity and accepts
amphipathic organic anions, cardiac glycosides (digoxin and ouabain; a
neutral compound), and organic cations (rocuronium and
N-(4,4-azo-n-pentyl)-21-deoxyajamalinium).
In the present study, kinetic analyses were carried out to investigate
whether taurocholate (TCA), digoxin, and
17
-estradiol-D-17
glucuronide (E217
G)
share the same recognition site on rOatp2 for their transport. The
transport of TCA and digoxin was mutually inhibited, and the Ki values of digoxin and TCA for the
transport of TCA and digoxin were 0.58 and 160 µM, respectively. The
Km and Vmax
values of TCA and digoxin were 190 µM and 140 pmol/min/mg of protein
and 1.1 µM and 6.6 pmol/min/mg of protein, respectively. The
Km and Ki values
were consistent. In addition, digoxin (1 µM) and TCA (100 µM)
increased the Km values of TCA and digoxin,
respectively, but they did not affect the
Vmax values, suggesting that their inhibition is competitive. The transport of digoxin via rOatp2 was
inhibited slightly by E217
G, whereas the uptake of TCA
was stimulated by E217
G in a concentration-dependent
manner. These results suggest that rOatp2 has at least two substrate
recognition sites, one for TCA and digoxin and the other for
E217
G.
This article has been cited by other articles:
![]() |
D. E. Westholm, D. R. Salo, K. J. Viken, J. N. Rumbley, and G. W. Anderson The Blood-Brain Barrier Thyroxine Transporter Organic Anion-Transporting Polypeptide 1c1 Displays Atypical Transport Kinetics Endocrinology, November 1, 2009; 150(11): 5153 - 5162. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Nakakariya, Y. Shima, Y. Shirasaka, K. Mitsuoka, T. Nakanishi, and I. Tamai Organic anion transporter OAT1 is involved in renal handling of citrulline Am J Physiol Renal Physiol, July 1, 2009; 297(1): F71 - F79. [Abstract] [Full Text] [PDF] |
||||
![]() |
K.-i. Umehara, M. Iwai, Y. Adachi, T. Iwatsubo, T. Usui, and H. Kamimura Hepatic Uptake and Excretion of (-)-N-{2-[(R)-3-(6,7-Dimethoxy-1,2,3,4-tetrahydroisoquinoline-2-carbonyl)piperidino]ethyl}-4-fluorobenzamide (YM758), a Novel If Channel Inhibitor, in Rats and Humans Drug Metab. Dispos., June 1, 2008; 36(6): 1030 - 1038. [Abstract] [Full Text] [PDF] |
||||
![]() |
X. Wang, A. W. Wolkoff, and M. E. Morris FLAVONOIDS AS A NOVEL CLASS OF HUMAN ORGANIC ANION-TRANSPORTING POLYPEPTIDE OATP1B1 (OATP-C) MODULATORS Drug Metab. Dispos., November 1, 2005; 33(11): 1666 - 1672. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. P. Annaert and K. L. R. Brouwer ASSESSMENT OF DRUG INTERACTIONS IN HEPATOBILIARY TRANSPORT USING RHODAMINE 123 IN SANDWICH-CULTURED RAT HEPATOCYTES Drug Metab. Dispos., March 1, 2005; 33(3): 388 - 394. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Tohyama, H. Kusuhara, and Y. Sugiyama Involvement of Multispecific Organic Anion Transporter, Oatp14 (Slc21a14), in the Transport of Thyroxine across the Blood-Brain Barrier Endocrinology, September 1, 2004; 145(9): 4384 - 4391. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Imaoka, H. Kusuhara, S. Adachi-Akahane, M. Hasegawa, N. Morita, H. Endou, and Y. Sugiyama The Renal-Specific Transporter Mediates Facilitative Transport of Organic Anions at the Brush Border Membrane of Mouse Renal Tubules J. Am. Soc. Nephrol., August 1, 2004; 15(8): 2012 - 2022. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Houle, J. Raoul, J.-F. Levesque, K. S. Pang, D. A. Nicoll-Griffith, and J. M. Silva Retention of Transporter Activities in Cryopreserved, Isolated Rat Hepatocytes Drug Metab. Dispos., April 1, 2003; 31(4): 447 - 451. [Abstract] [Full Text] [PDF] |
||||